This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet Healthcare (THC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 112.50% and 2.87%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Is Tenet Healthcare (THC) a Good Stock for Value Investors?
by Zacks Equity Research
Let's see if Tenet Healthcare Corporation (THC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Here's Why You Should Add Tenet Healthcare to Your Portfolio
by Zacks Equity Research
Riding high on a solid inorganic growth profile and divestitures, Tenet Healthcare (THC) holds ample chances of reaping benefits for investors.
Will Tenet Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Tenet Healthcare.
5 Excellent GARP Picks With Discounted PEG
by Zacks Equity Research
Although PEG ratio is categorized under value investing, this strategy follows the principles of both growth and value investing.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) fourth-quarter results reflect earnings decline due to a decrease in operating revenues.
Tenet Healthcare (THC) Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Tenet Healthcare's (THC) Q4 earnings are likely to suffer lower admissions due to divestitures.
Earnings Preview: Tenet Healthcare (THC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare (MOH) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter earnings trump estimates on the back of lower costs and higher premium revenues.
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) fourth-quarter earnings rise on the back of solid segmental growth.
MEDNAX (MD) Q4 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Mednax's (MD) Q4 gains on revenue growth. However, the same is partly offset by rise in expenses.
Is a Beat in Store for Molina Healthcare (MOH) Q4 Earnings?
by Zacks Equity Research
Molina Healthcare (MOH) is expected to gain in Q4 on the back of membership strength and its streamlining initiative. However, the same might be partly offset by a dismal Marketplace business.
WellCare Health (WCG) Q4 Earnings Beat Estimates, Soar Y/Y
by Zacks Equity Research
WellCare Health's (WCG) Q4 earnings gain from Meridian buyout and growth in membership.
Humana's (HUM) Q4 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter earnings gain on the back of Medicare Advantage membership growth and operating efficiencies.
Centene's (CNC) Earnings Top Estimates in Q4, Surge Y/Y
by Zacks Equity Research
Centene's (CNC) Q4 earnings ride high on robust revenues, solid acquisitions and stronger Health Insurance Marketplace business.
What's in Store for Humana (HUM) Stock in Q4 Earnings?
by Zacks Equity Research
Higher enrollment and strong segmental results are expected to help Humana (HUM) in fourth-quarter earnings.
Cigna (CI) Poised to Beat Q4 Earnings on Revenue Growth
by Zacks Equity Research
Cigna's (CI) Q4 results are likely to gain from increase in revenues and membership.
UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable
by Zacks Equity Research
UnitedHealth (UNH) shares gained following a strong fourth-quarter results, operating fundamentals point to a solid 2019
UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results gain from higher revenues and membership.
Tenet (THC) Signs Deal to Provide Services to Cigna Members
by Zacks Equity Research
Tenet (THC) enters new agreements to provide in-network access to Cigna members
Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns
by Zacks Equity Research
The hospital industry should grow on increased demand from an aging population, rising incidence of disease and technological innovation amid shortage of labor and shift of care to a low-cost setting.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.